Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.500
+0.250 (11.11%)
At close: Dec 20, 2024, 4:00 PM
2.600
+0.100 (4.00%)
After-hours: Dec 20, 2024, 7:59 PM EST
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $69.61 million as of December 20, 2024. Its market cap has decreased by -47.11% in one year.
Market Cap
69.61M
Enterprise Value
-26.18M
1-Year Change
-47.11%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $69.61M, an increase of 648.48%. That is a compound annual growth rate of 26.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 69.60M | -49.89% |
Dec 29, 2023 | 138.90M | 552.11% |
Dec 30, 2022 | 21.30M | -94.53% |
Dec 31, 2021 | 389.40M | 171.17% |
Dec 31, 2020 | 143.60M | 381.88% |
Dec 31, 2019 | 29.80M | -36.05% |
Dec 31, 2018 | 46.60M | 258.46% |
Dec 29, 2017 | 13.00M | -58.47% |
Dec 30, 2016 | 31.30M | 236.56% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
HeartBeam | 63.46M |
SELLAS Life Sciences Group | 63.20M |
Burning Rock Biotech | 63.09M |
IceCure Medical | 63.00M |
Forian | 62.65M |
BeyondSpring | 62.47M |
Milestone Scientific | 62.31M |
Verrica Pharmaceuticals | 61.25M |